Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Ligand Pharmaceuticals Incorporated
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company. It operates as a royalty aggregator, partnering with biopharmaceutical companies to finance and advance late-stage clinical development programs. It owns and manages portfolios of biopharmaceutical royalties, with economic interests in more than 200 development and commercial-stage assets. It funds high-value programs in exchange for long-term economic interests. It also licenses its proprietary technologies, Captisol and NITRICIL, to support drug development and formulation across its global partner network. Its commercial products include Roche's VABYSMO (faricimab-svoa), Servier's OJEMDA (tovorafenib), and Zevra Therapeutics' MIPLYFFA (arimoclomol). Additionally, it includes 14 late-stage development programs, featuring Takeda’s mezagitamab and certain assets from Takeda’s externalized asset portfolio, such as osavampator, volixibat, and OHB-607, along with more than 100 assets in various stages of development.
Find out what a historical investment in Ligand Pharmaceuticals Incorporated would be worth today using our LGND stock calculator.
Market Capitalisation
$5.89B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
111.69K
High today
$305.00
Low today
$295.35
Open price
$296.97
52-week high
$326.63
52-week low
$129.55
Ready to start your investing journey with Stake?
Open an accountHow do I buy LGND shares in Australia?
Buying LGND shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Ligand Pharmaceuticals Incorporated in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LGND
What is the ticker symbol of Ligand Pharmaceuticals Incorporated?
The ticker symbol for Ligand Pharmaceuticals Incorporated is LGND.
How much is one share of LGND?
One share of LGND is valued at $304.19 as of 21 July 2026.
What is the market capitalisation of Ligand Pharmaceuticals Incorporated LGND?
As of 21 July 2026 Ligand Pharmaceuticals Incorporated has a market cap of $5.89B.
What is the P/E ratio of LGND?
The Price to Earnings ratio of LGND is 39.60.
What is the Earnings Per Share of LGND?
The Earnings Per Share of LGND is $7.42.
What is the 52-week high for Ligand Pharmaceuticals Incorporated stock?
The Ligand Pharmaceuticals Incorporated 52-week high stock price is $326.63.
What is the 52-week low for Ligand Pharmaceuticals Incorporated stock?
The Ligand Pharmaceuticals Incorporated 52-week low stock price is $129.55.
Can I buy LGND shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LGND shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LGND on Stake
- Buy LGND from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of LGND from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
LGND related stocks